A Vaccine Communication Training Intervention for Pediatric Inpatient Clinicians

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorSeattle Children's Hospital

About this trial

This study will examine a novel stakeholder-informed intervention to identify vaccine-eligible children and promote evidence-based clinician vaccine communication with families with the goal of increasing vaccine uptake during hospitalization.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Hospitalized on medical or surgical unit (non-critical care) at Seattle Children's

Age 0-17 years during hospitalization

Eligible for vaccination during hospitalization

Disqualifiers

Medical contraindication to vaccination

Died during hospitalization

Discharged from intensive care unit

Discharged to hospice care

Trial design

Design model

Sequential

Treatments tested in this trial

  • PIVOT-IN

    Behavioral

    Inpatient clinicians at Seattle Children's Hospital, including nurses, advanced practice providers, and physicians, will be trained using the 'Presumptively Initiating Vaccines and Optimizing Talk for Inpatients (PIVOT-IN)' curriculum. During this training, inpatient clinicians will learn, practice, and use a presumptive format to initiate their vaccine recommendations and motivational interviewing techniques in their vaccine conversations with hospitalized patients and families.

  • Standardized Vaccine Eligibility Screening

    Other intervention

    An electronic health record prompt to identify patients due or overdue for vaccines was activated by the hospital in September.

Treatment groups

2,000 Participants
are divided into 3 treatment groups
Group A: BaselineNo intervention 0 interventions
Group B: Standardized Vaccine Eligibility ScreeningOther 1 intervention
Group C: Vaccine Communication TrainingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Percentage of vaccine-eligible hospitalized patients who receive routine childhood vaccines during hospitalization

The percentage of vaccine-eligible hospitalized patients who receive one or more needed routine childhood vaccines (non-influenza, non-COVID-19) during hospitalization will be calculated using patient electronic health record data. Vaccine eligibility at hospital admission will be determined based upon the patient's age and, if applicable, underlying medical conditions or treatment regimens, per American Academy of Pediatrics recommendations for routine childhood vaccination.

Time frame
Hospital admission to discharge (up to 7 months or the intervention end date, whichever comes first)

Secondary outcomes

1

Number of clinicians who complete the PIVOT-IN vaccine communication curriculum

The number of clinicians who complete the 3 main activities in the PIVOT vaccine communication curriculum will be calculated: (a) view the introductory video; (b) participate in the initial training session; and (c) participate in the refresher training session based upon the study's curriculum activity tracking log.

Time frame
Up to 8 months after the intervention start date
2

Change in clinicians' perceived self-efficacy in discussing vaccines

To assess the change in clinicians' perceived self-efficacy in discussing vaccines with hospitalized patients and families, a survey of all participating clinicians will be administered at baseline and at study completion. The survey will ask about the clinician's perceived impact on parental decision-making about vaccine administration during hospitalization. Self-efficacy will be assessed with a 2-part question scored on a 4-point Likert Scale (Strongly Disagree, Somewhat Disagree, Somewhat Agree, Strongly Agree). Changes in perceived self-efficacy over time will be assessed by comparing the percentage of clinicians who answered "Strongly Agree" or "Somewhat Agree" to the statement "I am influential in caregivers' decisions about whether or not to get vaccines for their hospitalized child" at baseline and post-intervention.

Time frame
At Baseline and Post-Intervention (up to 10 months after the intervention start date)
3

Change in clinicians' reported use of a presumptive approach to initiate their vaccine recommendation

To assess the change in clinicians' reported use of a presumptive approach to initiate their vaccine recommendation with hospitalized patients and families, a survey of all participating clinicians will be administered at baseline and at study completion. The survey will ask about the clinician's approach to initiating their vaccine recommendation with hospitalized patients and families. A presumptive approach will be defined as a response of "telling the caregivers which shots their child would be getting without asking their opinion" or "telling the caregivers which shots their child would be getting and then asking their opinion about that shot plan." Changes over time will be assessed by comparing the percentage of clinicians who reported use of a presumptive approach to initiate their vaccine conversation at baseline and post-intervention.

Time frame
At Baseline and Post-Intervention (up to 10 months after the intervention start date)
4

Perceived feasibility of the PIVOT-IN vaccine communication curriculum

To assess the perceived feasibility of the PIVOT-IN vaccine communication curriculum, a survey of all participating clinicians will be administered at study completion. The validated Feasibility of Intervention Measure (FIM), which includes 4 items to evaluate feasibility on a 5-point Likert scale, will be used. The score mean and standard deviation will be calculated. A higher score indicates greater perceived feasibility.

Time frame
Up to 2 months after the intervention end date

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Seattle Children's Hospital

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

University of Washington

Collaborator

National Institutes of Health (NIH)

Collaborator

This trial is not recruiting at the moment. You can still explore other options: